338 related articles for article (PubMed ID: 9231672)
21. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
22. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
23. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
[TBL] [Abstract][Full Text] [Related]
24. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
25. Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma.
Strnad V; Lotter M; Kreppner S; Fietkau R
Brachytherapy; 2014; 13(2):187-95. PubMed ID: 24211123
[TBL] [Abstract][Full Text] [Related]
26. Constraints in the use of repair half times and mathematical modelling for the clinical application of HDR and PDR treatment schedules as an alternative for LDR brachytherapy.
Pop LA; van den Broek JF; Visser AG; van der Kogel AJ
Radiother Oncol; 1996 Feb; 38(2):153-62. PubMed ID: 8966228
[TBL] [Abstract][Full Text] [Related]
27. Carcinoma of the tonsillar fossa: prognostic factors and long-term therapy outcome.
Perez CA; Patel MM; Chao KS; Simpson JR; Sessions D; Spector GJ; Haughey B; Lockett MA
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1077-84. PubMed ID: 9869232
[TBL] [Abstract][Full Text] [Related]
28. Institutional experience of interstitial brachytherapy for head and neck cancer with a comparison of high- and low dose rate practice.
Mohanti BK; Sahai P; Thakar A; Sikka K; Bhasker S; Sharma A; Sharma S; Bahadur S
Asian Pac J Cancer Prev; 2014; 15(2):813-8. PubMed ID: 24568501
[TBL] [Abstract][Full Text] [Related]
29. Exclusive brachytherapy for T1 and T2 squamous cell carcinomas of the velotonsillar area: results in 44 patients.
Le Scodan R; Pommier P; Ardiet JM; Montbarbon X; Malet C; Favrel V; Zrounba P; Poupart M; Céruse P; Ferlay C; Clippe S
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):441-8. PubMed ID: 16168837
[TBL] [Abstract][Full Text] [Related]
30. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
[TBL] [Abstract][Full Text] [Related]
31. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
Wong FC; Tung SY; Leung TW; Sze WK; Wong VY; Lui CM; Yuen KK; O SK
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1254-64. PubMed ID: 12654435
[TBL] [Abstract][Full Text] [Related]
32. Iridium 192 implantation of squamous cell carcinomas of the oropharynx.
Mazeron JJ; Crook J; Martin M; Peynegre R; Pierquin B
Am J Otolaryngol; 1989; 10(5):317-21. PubMed ID: 2683825
[TBL] [Abstract][Full Text] [Related]
33. Biological effect of pulsed dose rate brachytherapy with stepping sources if short half-times of repair are present in tissues.
Fowler JF; Van Limbergen EF
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):877-83. PubMed ID: 9128965
[TBL] [Abstract][Full Text] [Related]
34. Interstitial pulsed-dose-rate brachytherapy for the treatment of squamous cell anal carcinoma: A retrospective single institution analysis.
Boukhelif W; Ferri-Molina M; Mazeron R; Maroun P; Duhamel-Oberlander AS; Dumas I; Martinetti F; Guemnie-Tafo A; Chargari C; Haie-Meder C
Brachytherapy; 2015; 14(4):549-53. PubMed ID: 25935731
[TBL] [Abstract][Full Text] [Related]
35. Early results of pulsed-dose-rate interstitial brachytherapy for head and neck malignancies after limited surgery.
Strnad V; Lotter M; Grabenbauer G; Sauer R
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):27-30. PubMed ID: 10656368
[TBL] [Abstract][Full Text] [Related]
36. High dose rate versus low dose rate interstitial radiotherapy for carcinoma of the floor of mouth.
Inoue T; Inoue T; Yamazaki H; Koizumi M; Kagawa K; Yoshida K; Shiomi H; Imai A; Shimizutani K; Tanaka E; Nose T; Teshima T; Furukawa S; Fuchihata H
Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):53-8. PubMed ID: 9588917
[TBL] [Abstract][Full Text] [Related]
37. Seven fractions of twice daily high dose-rate brachytherapy for node-negative carcinoma of the mobile tongue results in loss of therapeutic ratio.
Lau HY; Hay JH; Flores AD; Threlfall WJ
Radiother Oncol; 1996 Apr; 39(1):15-8. PubMed ID: 8735489
[TBL] [Abstract][Full Text] [Related]
38. Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer.
Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K
Radiother Oncol; 2003 Aug; 68(2):123-8. PubMed ID: 12972306
[TBL] [Abstract][Full Text] [Related]
39. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
40. Velotonsillar squamous cell carcinoma: 277 cases treated by combined external irradiation and brachytherapy--results according to extension, localization, and dose rate.
Pernot M; Malissard L; Taghian A; Hoffstetter S; Luporsi E; Forçard JJ; Aletti P; Bey P
Int J Radiat Oncol Biol Phys; 1992; 23(4):715-23. PubMed ID: 1618663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
